Intelligo

Private limited company · Bergen

ROZH PHARMA AS

ActiveRetail sale of pharmaceutical products (47.730)

Founded
16 Mar 2022
Employees
8
Chief executive
Rozh Noraldin Tofiq
Business address
c/o Rozh Noraldin Tofiq, Grimseidvegen 437D, 5259 Hjellestad

The life line 2022–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 21.8m.

  1. Managing director took office§ 07
  2. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

ROZH PHARMA AS is a private limited company in Bergen, founded in 2022, in the industry retail sale of pharmaceutical products. The chief executive is Rozh Noraldin Tofiq, and the chair of the board is Rozh Noraldin Tofiq. In 2025 the company had NOK 21.8m in operating revenue and a net profit of NOK 604k.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

2 changes, latest 15 Jul 2026

  • Annual accounts filed 2024 → 2025
  • Godkjente årsregnskap

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

1 point

  • OKEquity ratio 35.5%, above the industry median

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue NOK 21.8m in 2025

Revenue

NOK 21.8m

−3.3% from 2024

20232025

Operating profit

NOK 780k

−45.0% from 2024

20232025

Net profit

NOK 604k

−42.3% from 2024

20232025

Equity

NOK 1.6m

+48.0% from 2024

20232025

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Wages and social costs 14%
  • Depreciation 0%
  • Other operating costs 7%
  • Not specified in the source 75%
  • Left as operating result 4%

Of the net profit for 2025, NOK 524k stayed in the company. The rest, NOK 80k, is an assumed dividend.

The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026

Finances

§ 05 Financial health

Equity ratio 35.5%

RevenueNOK 21.8m Operating margin3.6% Equity ratio35.5% Revenue growth−3.3%
  • ROZH PHARMA AS, 2025
  • Industry median, assumed: NOK 19.4m · 2.5% · 14.5% · +6.6%

Equity NOK 1.6m36% of the assets (NOK 4.6m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 223 companies in 47.730 Retail sale of pharmaceutical products, not stated by the source.

Finances

§ 06 Accounts

4 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue21,76522,51920,492
Operating profit7801,4181,120
Profit before tax7751,3431,027
Net profit6041,047802
Total assets4,5514,4725,702
Equity1,6171,093347
Liabilities2,9343,3795,356

Source: the Register of Company Accounts, read 15 Nov 2026 · All 4 years →

Management and ownership

§ 07 Officers

4 officers now

The board: 1 member

Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 4 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

Styrets leder alene. Daglig leder alene.

May sign for the company:

Styrets leder alene. Daglig leder alene.

Power of procuration:

Daglig leder alene. Styrets leder alene.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 5 Oct 2026

Management and ownership

§ 09 Owners

None registered

No owners registered.The Tax Administration's shareholder register covers limited companies and has no owners for this business. Checked 15 Nov 2026.

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

2 connections

  • Person
  • Company

1 person links ROZH PHARMA AS to 1 other companies: Rozh Noraldin Tofiq 1.

Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →

Events and registers

§ 13 Events

3 since 2022

Events per year

20222026

  • Notices2
  • Register changes1

Since 2022: 2 announcements and 1 register change. Most happened in 2023 and 2024.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 18 Nov 2026. Register changes are Intelligo's own observations. · All 3 events →

Events and registers

§ 14 Notices

3, latest 11 Jun 2024

  • Godkjente årsregnskap
  • Godkjente årsregnskap
  • Nyregistrering i Foretaksregisteret

Source: The Brønnøysund Register Centre's announcements ↗, read 18 Nov 2026 · All 3 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 7 Apr 2022
  • VATRegistered
  • The Register of Business EnterprisesRegistered 7 Apr 2022
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Apotekdrift. Salg av legemidler, handelsvarer og medisinsk forbruksmateriell.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

None registered

No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 47.730

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

6 questions

  • Who is the chief executive of ROZH PHARMA AS?
    Rozh Noraldin Tofiq, since 2022. § 07
  • What was the revenue in 2025?
    NOK 21.8m in the company. § 06
  • Who can sign for ROZH PHARMA AS?
    Styrets leder alene. Daglig leder alene. § 08
  • Who is the auditor?
    AMICA REVISJON AS. § 07
  • Where is ROZH PHARMA AS based?
    c/o Rozh Noraldin Tofiq, Grimseidvegen 437D, 5259 Hjellestad.
  • When was ROZH PHARMA AS founded?
    16 Mar 2022, registered in the Register of Business Enterprises 7 Apr 2022. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose